Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-02 Sale |
2024-12-04 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director |
37,070 | $0.2702 | $10,016 | 4,000 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director |
134,713 | $0.2653 | $35,739 | 41,070 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
36,133 | $0.22 | $7,949 | 0 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
12,099 | $0.1969 | $2,382 | 0 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-20 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic |
46,657 | $0.2212 | $10,321 | 0 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO |
134,797 | $0.1998 | $26,932 | 0 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
137,803 | $0.2103 | $28,980 | 0 (Direct) |
View |
| 2024-09-10 Purchase |
2024-09-12 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
100,000 | $1.6124 | $161,240 | 124,552 (Direct) |
View |
| 2024-09-10 Purchase |
2024-09-12 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO |
100,000 | $1.6068 | $160,680 | 122,504 (Direct) |
View |
| 2024-06-28 Sale |
2024-07-02 4:15 pm |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
34,837 | $5.12 | $178,365 | 8,000 (Direct) |
View |
| 2024-04-03 Sale |
2024-04-05 4:30 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
10,451 | $4.95 | $51,732 | 0 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-02 4:58 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
150 | $4.9803 | $747 | 41,118 (Direct) |
View |
| 2023-12-21 Purchase |
2023-12-26 5:24 pm |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
904,977 | $4.42 | $3,999,998 | 1,789,093 (Indirect Direct) |
View |
| 2023-12-12 Sale |
2023-12-14 4:24 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
6,287 | $4.95 | $31,121 | 0 (Direct) |
View |
| 2023-12-06 Sale |
2023-12-08 4:23 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
6,287 | $3.95 | $24,834 | 6,287 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-31 Exercise |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director |
40,125 | $0 | 175,783 (Direct) |
View |
| 2024-10-31 Exercise |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
18,875 | $0 | 12,099 (Direct) |
View |
| 2024-10-31 Tax Withholding |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
6,776 | $2.09 | 12,099 (Direct) |
View |
| 2024-10-31 Exercise |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
18,875 | $0 | 137,803 (Direct) |
View |
| 2024-10-31 Tax Withholding |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
5,624 | $2.09 | 137,803 (Direct) |
View |
| 2024-10-31 Exercise |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO |
17,000 | $0 | 130,797 (Direct) |
View |
| 2024-10-31 Tax Withholding |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO |
8,707 | $2.09 | 130,797 (Direct) |
View |
| 2024-10-31 Exercise |
2024-11-04 5:00 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
17,000 | $0 | 36,133 (Direct) |
View |
| 2024-10-31 Tax Withholding |
2024-11-04 5:00 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
6,104 | $2.09 | 36,133 (Direct) |
View |
| 2024-09-30 Exercise |
2024-10-02 5:00 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic |
10,000 | $0 | 66,657 (Direct) |
View |
| 2024-09-30 Tax Withholding |
2024-10-02 5:00 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic |
3,100 | $2.1 | 66,657 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 5:00 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
2,667 | $0 | 12,000 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 5:00 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
2,667 | $0 | 13,334 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director |
10,000 | $0 | 141,658 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
10,000 | $0 | 48,837 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | TYSON TIMOTHY Director |
10,000 | $0 | 39,189 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director |
10,000 | $0 | 22,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | OH ANDREW M. Director |
10,000 | $0 | 22,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director |
10,000 | $0 | 22,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director |
10,000 | $0 | 22,000 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:42 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
4,000 | $0 | 12,000 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:41 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
4,000 | $0 | 6,666 (Direct) |
View |
| 2024-03-31 Exercise |
2024-04-02 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
13,666 | $0 | 52,571 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-02 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
4,218 | $5.12 | 52,571 (Direct) |
View |
| 2024-03-31 Exercise |
2024-04-02 4:59 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director |
45,566 | $0 | 222,792 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-02 4:59 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A Director |
14,052 | $5.12 | 222,792 (Direct) |
View |
| 2024-03-31 Exercise |
2024-04-02 4:58 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
15,333 | $0 | 41,118 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-02 4:58 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
4,732 | $5.12 | 41,118 (Direct) |
View |
| 2024-03-28 Tax Withholding |
2024-04-02 4:57 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic |
7,046 | $5.59 | 39,757 (Direct) |
View |
| 2024-03-27 Exercise |
2024-04-02 4:57 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Quirk Gerald E Chief Legal & Compliance Offic |
22,500 | $0 | 39,757 (Direct) |
View |
| 2024-03-31 Exercise |
2024-04-02 4:54 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
15,333 | $0 | 55,219 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-02 4:54 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
4,732 | $5.12 | 55,219 (Direct) |
View |
| 2024-03-31 Exercise |
2024-04-02 4:52 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO |
13,666 | $0 | 49,838 (Direct) |
View |
| 2024-04-01 Tax Withholding |
2024-04-02 4:52 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO |
3,500 | $5.12 | 49,838 (Direct) |
View |
| 2023-12-02 Option Award |
2023-12-05 5:28 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO |
86,000 | $0 | 86,000 (Direct) |
View |